JOHN EMERICK: Open Payments
NPI 1437812310 · YPSILANTI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,266 in 118 payments from 22 companies in 2025. Trend: 2023 $617 · 2024 $875 · 2025 $2,266
Food & beverage: $2,266
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $471 |
| Otsuka America Pharmaceutical, Inc. | 15 | $248 |
| Novo Nordisk Inc | 13 | $229 |
| Lilly USA, LLC | 13 | $190 |
| PFIZER INC. | 7 | $183 |
| Vanda Pharmaceuticals Inc. | 4 | $121 |
| ABBVIE INC. | 6 | $110 |
| GlaxoSmithKline, LLC. | 4 | $91 |
| Exact Sciences Corporation | 5 | $89 |
| Alkermes, Inc. | 3 | $80 |
Products named: CAPLYTA, REXULTI, MOUNJARO, Wegovy, ELIQUIS, FANAPT, VRAYLAR, TRELEGY ELLIPTA.
Industry payments across MI — which companies pay providers there.
